Do you want to read an article? Please log in or register.
Immune Checkpoint Inhibitors for Brain Metastases: A Primer for Neurosurgeons
Further Publications NeurologyFurther Publications Psychiatry
Related content
Migraine and Headache
Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature
Eur J Cancer.
Cuzzubbo S, Javeri F, Tissier M, Roumi A, Barlog C, Doridam J, Lebbe C, Belin C, Ursu R, Carpentier AF
doi: 10.1016/j.ejca.2016.12.001.
Further Publications NeurologyFurther Publications Psychiatry
Neurotoxicity associated with cancer immunotherapy: immune checkpoint inhibitors and chimeric antigen receptor T-cell therapy
Curr Opin Neurol.
Perrinjaquet C, Desbaillets N,
Hottinger AF
doi: 10.1097/WCO.0000000000000686.
Further Publications Neurology
Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases
Eur J Cancer
Hilbers ML, Dimitriou F, Lau P, Bhave P, McArthur GA, Zimmer L, Kudura K, Gérard CL, Levesque MP, Michielin O, Dummer R, Cheng PF, Mangana J
doi: 10.1016/j.ejca.2021.07.028
RECOMMENDED
Further Publications NeurologyFurther Publications Psychiatry
Severe neurological toxicity of immune checkpoint inhibitors: growing spectrum
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Ann Neurol.
Dubey D, David WS, Reynolds KL, Chute DF, Clement NF, Cohen JV, Lawrence DP, Mooradian MJ, Sullivan RJ, Guidon AC
doi: 10.1002/ana.25708.
RECOMMENDED
Further Publications NeurologyFurther Publications Psychiatry
Changing Therapeutic Landscape for Melanoma With Multiple Brain Metastases
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
doi: 10.1093/neuros/nyaa076.
BRAF V600 Mutation and BRAF Kinase Inhibitors in Conjunction With Stereotactic Radiosurgery for Intracranial Melanoma Metastases: A Multicenter Retrospective Study
Neurosurgery.
Mastorakos P, Xu Z, Yu J, Hess J, Qian J, Chatrath A, Taylor DG, Kondziolka D, Warnick R, Chiang V, Sheehan J
doi: 10.1093/
Further Publications Neurology
Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma
JAMA Oncol
Hirsch L, Martinez Chanza N, Farah S, Xie W, Flippot R, Braun DA, Rathi N, Thouvenin J, Collier KA, Seront E, de Velasco G, Dzimitrowicz H, Beuselinck B, Xu W, Bowman IA, Lam ET, Abuqayas B, Bilen MA, Varkaris A, Zakharia Y, Harrison MR, Mortazavi A, Barthélémy P, Agarwal N, McKay RR, Brastianos PK, Krajewski KM, Albigès L, Harshman LC, Choueiri TK
doi: 10.1001/jamaoncol.2021.4544
RECOMMENDED
Multiple Sclerosis
Central Slab versus Whole Brain to Measure Brain Atrophy in Multiple Sclerosis
Eur Neurol.
Ruberte E, Sinnecker T, Amann M, Gaetano L, Naegelin Y, Penner IK, Kuhle J, Derfuss T, Kappos L, Granziera C, Wuerfel J, Yaldizli Ö
doi: 10.1159/000495798.
Multiple Sclerosis
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
Brain
Barro C, Benkert P, Disanto G, Tsagkas C, Amann M, Naegelin Y, Leppert D, Gobbi C, Granziera C, Yaldizli Ö, Michalak Z, Wuerfel J, Kappos L, Parmar K, Kuhle J
doi: 10.1093/brain/awy154.